CMP vs Fascia Iliaca Block

计划入组 40 人 · 首次发布于 2020 年 6 月 11 日

CMP-001 for Relapsed and Refractory Lymphoma

计划入组 14 人 · 首次发布于 2019 年 6 月 12 日

Clinical Study of CMP-001 in Combination With Pembrolizumab or as a Monotherapy

计划入组 199 人 · 首次发布于 2016 年 2 月 11 日

CMP-3

CMP-3013

CMP-1

CMP Pharma, Inc.

United States

CMP Therapeutics Ltd.

United Kingdom

CMP Development LLC

United States

Marchesini Group to Showcase Pharma and Aseptic Packaging Innovations at CPHI 2026 in Milan

CAMP4 Therapeutics Advances SYNGAP1 Gene Therapy Toward Clinical Testing with GLP Toxicology Studies

Brenntag Specialties Acquires Czech Firm mcePharma to Expand GMP Capabilities Across EMEA Region